Why Is Emerson Stock Falling Wednesday?

All NewsNovember 5, 2025

Emerson (NYSE: EMR) reports Q4 FY25 revenue of $4.86B, adjusted EPS $1.62 in line with estimates, while free cash flow declines 7% Y/Y.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent